Table I.
Association of miR-100 expression with clinicopathological variables of EOC patients.
| Low miR-100 expression (n=50) | High miR-100 expression (n=48) | ||
|---|---|---|---|
|
|
|
||
| Variables | n (%) | n (%) | P-value |
| Age (years) | 0.155 | ||
| ≥50 | 36 (72.0) | 28 (58.3) | |
| <50 | 14 (28.0) | 20 (41.7) | |
| Histological type | 0.486 | ||
| Serous | 16 (32.0) | 11 (22.9) | |
| Mucinous | 21 (42.0) | 20 (41.7) | |
| Others | 13 (26.0) | 17 (35.4) | |
| Histological grade | 0.849 | ||
| G1 | 25 (50.0) | 22 (45.8) | |
| G2 | 10 (20.0) | 9 (18.8) | |
| G3 | 15 (30.0) | 17 (35.4) | |
| FIGO stage | 0.001 | ||
| I/II | 14 (28.0) | 29 (60.4) | |
| III/IV | 36 (72.0) | 19 (39.6) | |
| Residual tumor diameter (cm) | 0.366 | ||
| <1.0 | 20 (40.0) | 15 (31.3) | |
| ≥1.0 | 30 (60.0) | 33 (68.7) | |
| Ascites | 0.279 | ||
| No | 22 (44.0) | 16 (33.3) | |
| Yes | 28 (56.0) | 32 (66.7) | |
| Serum CA125 level (U/l) | 0.001 | ||
| <5.0×105 | 15 (30.0) | 30 (62.5) | |
| ≥5.0×105 | 35 (70.0) | 18 (37.5) | |
| Lymph node involvement | 0.014 | ||
| No | 21 (42.0) | 32 (66.7) | |
| Yes | 29 (58.0) | 16 (33.3) |